特殊血液净化技术应用于重症新型冠状病毒肺炎的专家共识

Expert consensus on special blood purification technics in patients with corona virus disease 2019

重症新型冠状病毒肺炎(COVID-19)患者有较高的病死率。细胞因子风暴是COVID-19由轻型转为重症或危重症的病理生理基础。国家卫生健康委员会发布的《新型冠状病毒肺炎诊疗方案(试行第六版)》指出,对有高炎症反应的重危患者,有条件的可考虑使用血浆置换、吸附、灌流、血液/血浆滤过等体外血液净化技术。为更好地指导、规范血液净化技术在重症COVID-19的应用,中华医学会肾脏病学分会与中国研究型医院学会肾脏病学专业委员会专家组,针对血液净化技术在上述诊疗方案所提出的重症COVID-19患者如何开展血液净化技术治疗进行了充分讨论,制定了本共识。

The outbreak of corona virus disease 2019(COVID-19)has spread to more than 70 countries worldwide and there was a higher mortality in those who developed serious illness.Cytokine storm syndrome is an important pathophysiological basis for COVID-19 patients developing into severe or critical conditions.It was indicated in the diagnosis and treatment scheme,by the National Health Commission of the People′s Republic of China,that blood purifications such as plasma exchange,plasma adsorption,hemoperfusion,hemofiltration and plasmafiltration could be considered for use in the critical patients with cytokine storm syndrome.This expert consensus,proposed by the Chinese Society of Nephrology and the Nephrology Committee of Chinese Research Hospital Association,is to guide and standardize the clinical application of blood purifications in the treatment of severe or critical patients with COVID-19.